Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D004311:Double-Blind Method; D004958:Estradiol / Q000009:adverse effects; D045166:Estradiol Congeners / Q000009:adverse effects*; D004964:Estriol / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D045166:Estradiol Congeners; D004967:Estrogens; D008055:Lipids; D008074:Lipoproteins; D004997:Ethinyl Estradiol; D004958:Estradiol; D004964:Estriol; D009640:Norethindrone